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1. INTRODUCTION 
  Analytical chemistry is a measurement science consisting of a set powerful ideas 
and methods that is useful in all fields of science and medicine. Analytical Chemistry is 
applied throughout industry, medicine and all the sciences. 
Analytical chemistry can be split in to two main types 
                                a. Qualitative Analysis 
                                b. Quantitative Analysis 
a. Qualitative Analysis 
 Qualitative Analysis reveals the identity of the elements and compounds in a sample. 
 
b. Quantitative Analysis [Skoog, et al., Fundamentals of Analytical Chemistry     2007] 
 Quantitative Analysis indicates the amount of each substance in a sample. More 
commonly a separation step is a necessary part of the analytical process. 
 
Quality control is a concept which strives to produce a perfect product by series of 
measures designed to prevent and eliminate errors at different stages of production. The 
decision to release or reject a product is based on one or more type of control action. With 
the growth of pharmaceutical industry during last several years, there has been rapid 
progress in the field of pharmaceutical analysis involving complex instrumentation. 
Providing simple analytical procedure for complex formulation is a matter of most 
importance. So, it becomes necessary to develop new analytical methods for such drugs. In 
brief the reasons for the development of newer methods of drugs analysis are 
The drug or drug combination may not be official in any pharmacopoeias. 
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 A proper analytical procedure for the drug may not be available in the literature due to 
Patent regulations. 
 Analytical methods for a drug in combination with other drugs may not be available. 
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The Nature of Analytical Chemistry 
 
  
Change Chemical 
Carry out Chemical dissolution No 
Measurable Property  
Yes 
Eliminate 
Measure Property 
Calculate Results 
Estimate reliability of results  
Select Method 
Acquire sample 
Process sample 
Is sample soluble?  
Yes 
No 
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Factors affecting the choice of Analytical Methods 
  Analytical techniques have different degrees of sensitivity, Selectivity and 
Sophistication. An important task for the analyst is to select the best procedure for a given 
determination.  
a) The type of analysis is required.                    
b) The problem arising from the material to be investigated (Sample). 
c) Possible interference from components of the material other than those of     
interest. 
d) The concentration range. 
e) The accuracy required. 
f) The facilities available, particularly the instruments. 
g) The time required to complete the analysis. 
h) Similar type of analysis to be performed. 
 Different types of modern pharmaceutical analytical techniques used in pharmaceutical 
analysis 
A. Titrimetry  Methods 
1. Acid – Base titration 
2. Precipitation titration 
3. Redox titration 
B. Gravimetric Methods 
1. Weigh drug after extraction. 
2. Weigh a derivative after separation. 
3. Weighing the residue after ignition. 
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C. Spectrophotometric Methods 
1. Colorimetric method 
2. UV method 
3. Flourimetric method 
4. Flame photometry 
5. Atomic absorption spectroscopy 
6. Infrared spectroscopy 
7. Raman spectroscopy 
8. X-Ray spectroscopy 
9. Mass spectroscopy 
10. Dye complex method  
D. Electro Analytical Methods 
1. Potentiometry 
2. Voltametry 
3. Conductance techniques 
4. Electrogravimetry 
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E. Chromatographic  Methods 
1. Thin layer chromatography 
2. Column chromatography 
3. Paper chromatography 
4. Gas chromatography 
5. High Performance Liquid Chromatography 
F. Hybrid Techniques 
1. LC-MS 
2. HPLC/ESI-MS 
3. LC-DAD 
4. CE-MS 
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Table No: 1 Types of instrumental methods [Gurdeep R Chatwalet al., 2006] 
Signal Instrumental Methods 
Emission of radiation Emission spectroscopy, flame photometry, 
Fluorescence, radio chemical methods. 
 
Absorption of 
radiation 
Spectrophotometric and photometry (X-ray, UV, 
visible, IR); photo acoustic spectroscopy; nuclear 
magnetic resonance and electron spin resonance 
spectroscopy 
Scattering of radiation Turbidimetry; nephelometry; Raman spectroscopy 
Refraction of radiation Refractometry; Interferometry 
Diffraction of 
radiation 
X-Ray and electron diffraction methods 
Rotation of radiation Polarimetry;  optical rotary dispersion;  
Circular dichroism 
Electrical potential Potentiometry; chronopotentiometry 
Electrical charge Coulometer 
Electrical current Polarography; Amperometry 
Electrical resistance Conductimetry 
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Mass-to-charge ratio Mass spectrometry 
Rate of reaction Kinetic methods 
Thermal properties Thermal conductivity and enthalpy 
Radioactivity Activation and isotope dilution methods 
 
1.1 Ultra Violet Spectroscopy [Sharma, 1994] 
  Spectrophotometric is used for both qualitative and quantitative investigations of 
samples. Ultra Violet absorption spectroscopy deals with the measurement of energy 
absorbed when electrons are promoted to higher energy levels. The UV spectrum of a 
molecule results from transitions between electronic energy levels accompanied by 
changes in both vibrational and rotational states. 
 
The UV spectrum may be divided in to the following regions 
a. Far  (or)  Vaccum UV (10 – 200nm) 
b. Near  (or) Quartz UV (200 – 400nm) 
c. Visible region (400 – 800nm) 
 
Choice of solvent [Sharma 1994; Gurdeep R. Chatwal, et al., 2006] 
1. The solvent used should be high purity generally referred to as “Spectrograde”. 
2.  A good solvent should be transparent over the desired range of wavelengths. 
3. The compound should be a good solvent for dissolving the organic compound      
(Sample).      
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4. A solvent should be chosen so that it does not react chemically with the sample. 
Detectors 
            A detector is a transducer converting electromagnetic radiations in to an electron 
flow and subsequently in to a current flow (or) voltage in the read out circuit. Detectors 
used in UV- Visible Spectrophotometers can also be used as Photometric Detectors. The 
most commonly used detectors are,  
1. Barriers Layer Cell or Photo Voltaic cell 
2.  Photo tubes or photo emissive cells and  
3. Photo Multiplier tubes.  
 
1.2 INTRODUCTION TO CHROMATOGRAPHY [Sharma, et al., 2002; 
Beckett et al., 2007] 
           Chromatography may be defined as a method of separating a mixture of components 
through equilibrium distribution between two phases (Stationary Phase and Mobile Phase) 
Chromatography is a technique for separating mixtures  into their components in order to 
analyze, identify, purify, and/or quantify the mixture or components. 
 Analyze 
 Identify 
 Purify 
 Quantify 
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1.2.1 INTRODUCTION TO HPLC (Sethi P. D,2007, 2008) 
  HPLC was referred to as High pressure liquid chromatography but nowadays the 
term High Performance Liquid Chromatography. High performance liquid chromatography 
is the fastest growing analytical technique for the analysis of drugs. Its simplicity, high 
specificity and wide range of sensitivity make it ideal for the analysis of many drugs in 
both dosage forms and biological fluids. The principle of separation ii normal phase mode 
and reverse phase mode. Liquid chromatography is an analyticalchromatographic 
technique that is useful for separating ions or molecules that are dissolved in a solvent. RP-
HPLC usually is used because of convenience, wide applicability.Most of the multi 
component dosage forms can be analyzed by HPLC because of several advantages. 
 
1. No need any tedious extraction & Isolation process. 
2. Greater sensitivity (Due to several detectors). 
3. Better resolution due to wide variety of stationary phases. 
4. Instrumentation tends itself to automation and quantitation. 
  
 The separation is about 100 times faster than the conventional liquid chromatography due 
to packing of particles in the range of 3-10µm. Thus HPLC is having advantages of 
improved resolution, faster separation, improved accuracy, precision and sensitivity. 
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1.2.2 Different Types of Principles [Jeffery et al., 1989; Mendham et al., 2002; H. H  
Willard et al., 1986] 
HPLC can be classified into several types, which are as follows: 
1. Normal Phase Chromatography (NPC)  
2. Reverse – Phase Chromatography (RPC) 
3. Liquid – Solid Chromatography or adsorption HPLC  
4. Liquid – Liquid Chromatography or Partition HPLC  
5. Ion exchange Chromatography or Ion exchange HPLC  
6. Size exclusion or gel permeation or steric exclusion HPLC  
 
1. Normal Phase Chromatography (NPC)  
  Normal phase HPLC (NP-HPLC) in this method separation of analytes is based 
on polarity. If Compounds containing non polar groups means normal phase mode is used. 
In normal phase stationary phase is polar and Mobile phase is non polar. Sample retention 
in normal phase chromatography increases with the polarity of mobile phase decreases. 
They are eluted and detected in the order of increasing polarities. Hence this technique is 
not widely used in pharmacy. 
 
2. Reverse – Phase Chromatography (RPC) 
  This is widely used for analytical and preparative separations of compounds in 
chemical, biological, pharmaceutical, food and biomedical science. In Reverse phase 
chromatography stationary phase is non polar and mobile phase and polar. Hence polar 
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components get eluted first and non polar compounds are retained for a long time. Almost 
all the pharmaceuticals and the drugs are polar in nature and so they are not retained for a 
longer time and eluted faster. 
 Water < Methanol < Acetonitrile < Ethanol <Tetrahydrofuran< Propanol < Methylene 
chloride. 
 
3.  Liquid – Solid Chromatography or adsorption HPLC 
  The principal of separation is by means absorption. Separation of the components 
takes place because of the difference in affinity of components towards stationary phase. 
The interaction between the solute and the adsorbent is optimum when solute overlap with 
the absorbents. The adsorbent is made up of silica and alumina. This principle is seen in 
both NP-HPLC and RP-HPLC. 
 
4.  Liquid – Liquid Chromatography or Partition HPLC 
  Principle of separation is based on the partitions co-efficient. In these 
chromatography two types immiscible liquids are present. This form of chromatography is 
based on a thin film formed on the surface of a solid support by a liquid stationary phase. 
Solute equilibrates between the mobile phase and the stationary liquid. Mixture of sample 
is dissolved  in mobile phase and passed through a column of liquid stationary phase, The 
samples which are more soluble in stationary phase travels faster and samples which are 
more soluble in mobile phase travels faster. Thus the components are separated according 
to their partitions co-efficient.  
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5.  Ion exchange Chromatography or Ion exchange HPLC 
  The principle of separation of is by reversible exchange of ions between the ions 
present in the solution and those present in the ion exchange resin. Ion exchange is 
probably the most frequently used chromatographic technique for the separation and 
purification of proteins, polypeptides, nucleic acids, polynucleotide’s and other charged bio 
molecules. In this type of chromatography, the use of a resin (the stationary solid phase) is 
used to covalently attach anions or cations onto it. Solute ions of the opposite charge in the 
mobile liquid phase are attracted to the resin by means of electrostatic forces. 
 
6.  Size exclusion or gel permeation or steric exclusion HPLC 
  Gel Chromatography is a simple and reliable method for separating molecules 
according to size. A gel is used to separate the components from a mixture. Selectivity is 
based on steric factors between the adsorbate and the adsorbent is utilised in achieving in 
achieving specific separations through gel chromatography. It is usually applied to large 
molecules or macromolecular complexes such as proteins and industrial polymers. Gel 
chromatography has been used with great success in the separation of the sugars, 
polypeptides, proteins, liquids, asphalts, silicon polymers and others. 
 
1.2.3 INSTRUMENTATION OF HPLC: [http://webstore.idex-hs.com] 
  HPLC systems include a solvent reservoir, pump, injector, analytical column, 
detector, recorder and waste reservoir. Other important elements are an inlet solvent filter, 
post-pump inline filter, sample filter, precolumn filter, guard column, back- pressure 
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regulator and/or solvent sparing system. The function of each of these components is 
briefly described below. 
 
  HPLC system begins with the solvent reservoir, which contains the solvent used 
to carry the sample through the system. The solvent should be filtered with an inlet solvent 
filter to remove any particles that could potentially damage the system's sensitive 
components. Solvent is propelled through the system by the pump. This often 
includes internal pump seals, which slowly break down over time. As these seals break 
down and release particles into the flow path, an inline solvent filter prevents any post-
pump component damage. 
 
  The next component in the HPLC system is the sample injector, also known as the 
injection valve. This valve, equipped with a sample loop of the appropriate size for the 
analysis being performed, allows for the reproducible introduction of sample into the flow 
path. Because the sample often contains particulate matter, it is important to utilize either 
a sample filter or a pre column filter to prevent valve and column damage. 
 
  Next to the injector, an analytical column allows the primary sample separation to 
occur. This is based on the differential attraction of the sample components for the solvent 
and the packing material within the column. However, a sacrificial guard column is often 
included just prior to the analytical column to chemically remove components of the 
sample that would otherwise foul the main column. 
 
  Following the analytical column, the separated components pass through 
a detector flow cell before they pass into the waste reservoir. The sample components' 
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presence in the flow cell prompts an electrical response from the detector, which is 
digitized and sent to a recorder. The recorder helps analyze and interpret the data. 
 
  As a final system enhancement, a back pressure regulator is often installed 
immediately after the detector. This device prevents solvent bubble formation until the 
solvent is completely through the detector. This is important because bubbles in a flow cell 
can interfere with the detection of sample components. Alternatively, an inert gas sparing 
system may be installed to force dissolved gasses out of the solvent being stored in the 
solvent reservoir. Each of the components described above requires fittings to couple it 
into a system. It is important to note that improper selection or installation of these fittings 
can  lead to leaks or the formation of dead volume, both of which can result in poor HPLC 
performance 
 
 
 
 
 
 
 
 
 
 
 
Fig 1 Flow diagram of HPLC 
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1. Pump (H. H Willard et al., 1986; Douglas A Skooget al., 2007; Sharma, 2002) 
  Pumping system is one of the most important features of an HPLC system. There 
is a high resistance to solvent flow due to the narrow columns packed with small particles 
and high pressures are therefore required to achieve satisfactory flow rates. The main 
feature of a good pumping system is that it is capable of output of at least 3.4 × 107 Pa 
(5000 p.s.i.) and ideal there must be no pulses of flow through the system. This provides 
the constant and continuous flow of the mobile phase through the system; most modern 
pumps allow controlled mixing of different solvents from different reservoirs. The 
performance characteristics of the chromatographic pump and gradient makers 
fundamentally define and limit the kind of separations that can be performed on a liquid 
chromatographic system. 
Three types of pumps are available, 
1. Reciprocating pumps (90% of Commercial HPLC; produce pulse flow) 
2. Pneumatic pumps (cannot do gradient and pressure less than 2000 psi) 
3. Displacement pumps (produce flows that are independent of viscosity and back  
pressure) 
4. The former works by uniform displacement of fixed volume of mobile phase. 
 
 Modern pumps have the following parameters:   
 Flow rate range: 0.01 to 5 ml/min   
Flow rate stability: not more than 1%    
 For SEC flow rate stability should be less than 0.2%   
Maximum pressure: up to 300 hPa.   
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 It is desirable to have an integrated degassing system, either helium purging, or 
membrane filtering.  
 
2. Injector  
 Injector is required in LC than in GC since unwanted or interfering compounds, or 
both, may often be extracted, or eliminated, by selective detection. Sample introduction 
can be accomplished in various ways. The simplest method is to use an injection valve. In 
more sophisticated LC systems, automatic sampling devices are incorporated where the 
sample is introduced with the help of auto samplers and microprocessors.  In liquid 
chromatography, liquid samples may be injected directly and solid samples need only be 
dissolved in an appropriate solvent. The solvent need not be the mobile phase, but 
frequently it is judiciously chosen to avoid detector interference, column/component 
interference, loss in efficiency or all of these.  It is always best to remove particles from the 
sample by filtering over a 5 µm filter, or centrifuging, since continuous injections of 
particulate material will eventually cause  
blockages in injection devices or columns.   
 
  Sample sizes may vary widely. The availability of highly sensitive detectors 
frequently allows use of the small samples which yield the highest column performance. 
Typical sample mass with 4.6 mm ID columns range from the nanogram level up to about 
2 mg diluted in 20 ml of solvent. In general, it will be noted that much less sample 
preparation. 
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3. Columns 
Typical HPLC columns are 5, 10, 15 and 25 cm in length and are filled with small 
diameter (3, 5 or 10 µm) particles. The internal diameter of the columns is usually 4.6 mm; 
this is considered the best compromise for sample capacity, mobile phase consumption, 
speed and resolution. However, if pure substances are to be collected (preparative scale), 
then larger diameter columns may be needed. Packing the column tubing with small 
diameter particles requires high skill and specialized equipment. In general, LC columns 
are fairly durable and one can expect a long service life unless they are used in some 
manner which is intrinsically destructive, as for example, with highly acidic or basic 
eluents, or with continual injections of 'dirty' biological or crude samples. It is wise to 
inject some test mixture (under fixed conditions) into a column when new, and to retain the 
chromatogram.  If questionable results are obtained later, the test mixture can be injected 
again under specified conditions. The two chromatograms may be compared to establish 
whether or not the column is still useful.                          
 
 Different types of columns are used in HPLC. They are: 
a. Analytical column 
b. Inline filters  
c. Short column                                                                                                                
d. Narrow bore column                                                                                                                                            
e. Guard column 
f. Inline filters 
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4. Detectors  
  These are placed at the end of column and should be able to recognize when a 
substance zone eluted from the column. Nowadays optical detectors are used most 
frequently in liquid chromatographic systems. These detectors pass a beam of light through 
the flowing column effluent as it passes through a low volume (~ 10 µl) flow cell. The 
variations in light intensity caused by UV absorption, fluorescence emission or change in 
refractive index, from the sample components passing through the cell, are monitored as 
changes in the output voltage. These voltage changes are recorded on a strip chart recorder 
and frequently are fed into a computer to provide retention time and peak area data.  The 
most commonly used detector in LC is the ultraviolet absorption detector. A variable 
wavelength detector of this type, capable of monitoring from 190 to 400 nm, will be found 
suitable for the detection of the majority samples.   
 
Other detectors in common use include: 
Photo Diode Array UV detector (PAD) 
Refractive index (RI), 
Fluorescence (FLU), 
Electrochemical  (EC). 
 
 The RI detector is universal but also the less sensitive one. FLU and EC detectors are 
quite sensitive (up to 10-15 p mole) but also quite selective. 
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1.3 VARIOUS METHODS OF QUANTITATIVE ANALYSIS IN HPLC 
[Lloyd R Slyderet al., 1997; Sharma, 2002] 
  Quantative analysis in HPLC is used know the details about the developed peak 
and to describe various methods for obtaining quantitative information from 
chromatograms such as normalising peak areas, internal standards, external standards and 
standard addition methods in the  chromatography. Once the peak height or the peak areas 
are measured, there are five principle evaluation methods for quantifying the solute. 
1. Normalising Peak Areas Method 
2. Internal Standard Method 
3. External Standard Method 
4. Standard Addition Method 
5. Calibration by Standards 
 
1. Normalising Peak Areas Method 
Normalising Peak Areas Method is normally used for the sample which is having 
identical components and also used to evaluate the absolute purity of the sample. This 
procedure is total up the areas under all peaks and to find out the percentage of the total 
area that is contributed by the compound of interest. In this method the entire sample must 
be eluted, all components should be separated and each peak must be completely resolved 
to obtain the absolute purity of the sample. 
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2. Internal Standard Method 
  The internal standard methodis a variation on the above, and is recommended for 
accurate quantitative work. It eliminates the need for accurate injections since a reference 
standard is included in each sample analysed. Then a quantity of the internal standard is 
added to the raw sample prior to any sample pre treatment or separation operations. 
 
The peak area of the standard in the sample is allowed to run and is compared with 
the peak area when the standard is also run separately. This ratio serves as a correction 
factor for the variation in sample size for losses in any preliminary pre treatment operations 
or for incomplete elution of the sample. The material selected for the internal standard 
must be completely resolved from adjacent sample components and should not interfere 
with the sample components and should never be present in samples 
standardinternalofArea
sampleofAreaRatioArea   
standardtheofionConcentratx
standardinternalofArea
SampleofAreaionConcentratSample   
3. External Standard Method 
  This method separates the injection of a fixed volume of sample and standard 
solution. Here the peaks are integrated and concentration of the sample is calculated. 
 
standardtheofionConcentratx
standardinternalofArea
SampleofAreaionConcentratSample   
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4. Standard Addition Method 
  Standard addition methodis used in many techniques in analytical chemistry. It is 
of limited use in chromatography because of the difficulty of injecting accurately known 
amounts of sample. A sample mixture is analysed for the analytes of interest by adding a 
specified amount of this analytes to the sample, thus increasing its concentration. The 
analysis is then repeated and the resulting increase in peak area due to addition of the 
standard amount is noted. Hence, the concentration of the analytes in the original sample 
may be calculated. If only few samples are to be chromatographed, it is possible to employ 
the method of standard addition (s). 
  If an instrumental reading (area/height) ‘Rx’ is obtained, from a sample of 
unknown ‘x’ and a reading ‘Rt’ is obtained from the sample to which a known 
concentration ‘a’ of analytes has been added, then ‘x ’ can be calculated from.  
                   Rx
tR
XR
aX
X 

 
  A correction for dilution must be made if the amount of standard added changes 
the total sample volume significantly. It is always advisable to check the result by adding 
at least one other standard. 
 
 
 
 
 
 
                          Fig: 2 Calibration Curve of Standard Addition Method 
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4. Calibration by Standard 
Calibration curves for each component are prepared by using pure standards and by 
using identical injection volumes of operating conditions for standards and samples. The 
concentration of solute is read from its curve if the curve is linear. 
 
X = K x Area. 
                        Where, 
  X = Concentration of solute. 
K = Proportionality constant (slope of the curve). 
 
  In this method of evaluation only the area of the peaks of interest is measured. 
Relative response factors are considered when converting the areas to volume and when 
the response of a given detector differs for each molecular type of compounds. 
 
1.4 VALIDATION OF ANALYTICAL METHOD IN PHARMACEUTICAL 
ANALYSIS [Q2A- ICH Guidelines, 1994; Q2B- ICH Guidelines, 1996] 
When a method has been developed it is important to validate it to confirm that it 
is suitable for its intended purpose. The validation tells how good the methods are, 
specifically whether it is good enough for the intended application. The method validation 
is today an essential concern in the activity of analytical chemistry laboratories. It is 
already well implemented in pharmaceutical industry. However, in other fields like food, 
petrol chemistry or in the biotechnological field, regulations have not reached such a level 
of requirement. The US Food and Drug Administration (FDA) have edited draft 
guidelines with detailed recommendations for method validation of bio analytical methods 
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in the pharmaceutical industry. The International Conference on Harmonisation (ICH) has 
provided definitions of validation issues included in “analytical procedures” for the fields 
of bio analytical methodology, pharmaceutical and biotechnological procedures. Likewise 
the US Pharmacopeia (USP) has published guidelines for method validation for analytical 
methods for pharmaceutical products. However the guidelines from ICH and USP are not 
as detailed as those from the FDA, and in the analytical biotechnology area there exists no 
detailed validation guidelines. The most common validation parameters will be briefly 
described below. 
 
1.4.1 TYPES OF ANALYTICAL PROCEDURES TO BE VALIDATED (Q2A- ICH 
Guidelines, 1994; Q2B- ICH Guidelines, 1996) 
  The validation of analytical procedures is directed to the three most common 
types of analytical procedures 
 
 Quantitative tests for impurities' content. 
 Limit tests for the control of impurities. 
 Quantitative tests of the active moiety in samples of drug substance or drug product or 
other selected component(s) in the drug product. 
 Identification tests are intended to ensure the identity of an analytes in a sample this is 
normally achieved by comparison of a property of the sample to that of a reference 
standard. 
 Impurities can be tested by quantitative test or a limit test for the impurity in a sample. 
Either test is intended to accurately reflect the purity characteristics of the sample. 
Different validation characteristics are required for a quantitative test than for a limit test. 
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 Assay procedures are intended to measure the analytes present in a given sample. The 
same validation characteristics may also apply to assays associated with other analytical 
procedures. 
 
  The objective of the analytical procedure should be clearly understood since this 
will govern the validation characteristics which need to be evaluated. Typical validation 
characteristics which should be considered are listed below: 
1. Accuracy 
2. Precision 
a. Repeatability 
b. Intermediate Precision 
c. Reproducibility 
3. Specificity 
4. Detection Limit & Quantitation Limit 
5. Linearity 
6. Range 
7. Robustness 
8. Ruggedness 
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1. Accuracy 
                  “The accuracy of an analytical procedure expresses the closeness of agreement 
between the value which is accepted either as a conventional true value or an accepted 
reference value and the value found”.  Accuracy can be demonstrated by the following 
approaches: 
 Inferred from precision, linearity and specificity. 
 Comparison of the results with those of a well characterised, independent procedure. 
 Application to a reference material (for drug substance) 
 Recovery of drug substance spiked to placebo or drug product (for drug product). 
 Recovery of the impurity spiked to drug substance or drug product (for impurities). 
 
 For the quantitative approaches, at least nine determinations across the specified range 
should be obtained. 
2. Precision 
  “The precision of an analytical procedure expresses the closeness of agreement 
(degree of scatter) between a series of measurements obtained from multiple sampling of 
the same homogeneous sample under the prescribed conditions. Precision may be 
considered at three levels; repeatability, intermediate precision and reproducibility. 
 a. Repeatability 
  Repeatability expresses the analytical variability under the same operating 
conditions over a short interval of time (within-assay, intra-assay).Atleast nine 
determinations covering the specified range or six determinations  at 100% test 
concentration should be performed. 
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b. Intermediate Precision 
  Intermediate precision includes the influence of additional random  effects within 
laboratories, according to the intended use of the procedure, for example, different days, 
analysts or equipment, etc. 
 
c. Reproducibility 
  Reproducibility is the precision between laboratories (collaborative or inter 
Laboratory studies), is not required for submission, but can be taken into account for 
standardisation of analytical procedures. 
 
3. Specificity 
  Specificity is the ability to assess unequivocally the analytes in the presence of 
components which may be expected to be present. Typically these might include 
impurities, Degradants, Matrix, etc. Lack of specificity of an individual procedure may be 
compensated by other supporting analytical procedure. If specificity is not assured in the 
method, method Accuracy, precision and linearity all are seriously compromised. Method 
specificity should be reassessed continually during validation and subsequent use of the 
method 
 
 
 
. 
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4. Detection Limit & Quantitation Limit 
  The detection limit of an individual analytical procedure is the lowest amount of 
analytes in a sample which can be detected but not necessarily quantitated as an exact 
value. 
 
The detection limit (LOD) may be expressed as 
LOD = 3.3 s/ S 
Where,  
s = the standard deviation of the response. 
                        S = the slope of the calibration curve (of the analytes). 
  The quantitation limit of an individual analytical procedure is the lowest 
concentration of analytes in sample which can be quantitatively determined with suitable 
precision and accuracy. 
 
  Quantitation Limit (LOQ) may be expressed as 
LOQ = 10 s/S 
Where, 
s = the standard deviation of the response. 
S = the slope of the calibration curve (of the analytes). 
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5. Linearity 
  The linearity of an analytical procedure is its ability (within a given range) to 
obtain tests results which are directly proportional to the concentration (amount) of 
analytes in the sample. It may be demonstrated directly on the analytes, or on spiked 
samples using at least five concentrations over the whole working range. 
6. Range 
  The range of an analytical procedure is the interval between the upper and lower 
concentration (amounts) of analytes in the sample (including these concentrations) for 
which it has been demonstrated that the analytical procedure has a suitable level of 
precision, accuracy and linearity. The range of concentrations examined will depend on the 
type of method and its use. 
7. Robustness  
  The robustness of an analytical procedure is a measure of its capacity to remain 
unaffected by small, but deliberate variations in method parameters and provides an 
indication of its reliability during normal usage. The evaluation of robustness should be 
considered during the development phase and depends on the type of procedure under 
study. It should show the reliability of an analysis with respect to deliberate variations in 
method parameters. If measurements are susceptible to variations in analytical conditions, 
the analytical conditions should be suitably controlled or a precautionary statement should 
be included in the procedure. One consequence of the evaluation of robustness should be 
that a series of system suitability parameters (e.g., resolution test) is established to ensure 
that the validity of the analytical procedure is maintained whenever used. 
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8. Ruggedness 
  The ruggedness of an analytical method is the degree of reproducibility of test 
results obtained by the analysis of the same samples under a variety of conditions, such as 
different laboratories, different analysts, different instruments, different days, etc. 
Ruggedness is normally expressed as the lack of influence on test results of operational and 
environmental variables of the analytical method. Ruggedness is a measure of 
reproducibility of test results under the variation in conditions normally expected from 
laboratory to laboratory and from analyst to analyst. 
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                 Table No: 2   ACCEPTANCE CRITERIA OF VALIDATION FOR                        
        HPLC AND UV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Characteristics Acceptance Criteria 
1 Accuracy 
Recovery 98-102% with 80, 
100,120% spiked sample. 
2 Precision  
2.a Repeatability RSD < 2% 
2.b 
Intermediate 
precision 
RSD < 2% 
3 
Specificity/ 
selectivity 
No interference 
4 Quantitation Limit S/N > 10 
5 Detection Limit S/N > 2 or 3 
6 Range 80-120% 
7 Linearity r > 0.999 
8 Stability >24h or > 12h 
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1.4.2 SYSTEM SUITABILITY PARAMETERS [U.S.P, 1995] 
  System suitability is that checking of a system to ensure the system performance 
before or during the analysis of unknown/newer drug substances i.e., these tests are used to 
verify that the resolution and reproducibility for the analysis to be done. 
 
  These are numerous guidelines which explain the expected limits for typical 
chromatography methods. In the current FDA Guidelines on “Validation of 
chromatography methods” the following acceptance limits are proposed as initial criteria. 
   
1. Retention or Capacity factor (KA) 
2. Separation factor (α) 
3. Resolution (Rs) 
4. Selectivity (a) 
5. Theoretical factor or Column efficiency (N) and 
6. Peak asymmetry factor (As) 
 
1. Retention or Capacity factor (KA) 
  Capacity factor is the ratio of the reduced retention volume to the dead volume. 
[Then k’ is defined as the ratio of the number of molecules of the solute in the stationary 
phase to the number of molecules of the same in the mobile phase]. It is a measure of how 
well the same as the same molecule is retained by a column during an isocratic separation 
(It is the measure of a sample peak in the chromatogram being specific for a given 
Chapter 1 Introduction 
Dept. of Pharmaceutical Analysis 33 JKKMMRF College of Pharmacy 
compound).The ideal value of K’ ranges from 2-10. Capacity factor can be determined by 
using the formula. 
 
0t
0trtK

 
tr =   Retention time measured from time o injection to time of elution of peak                       
 maximum. 
to =      Void volume (Initial time) 
 
 Simply capacity factor is used to identify the location of the Sample (or) Specific peak. 
 
2. Separation factor (α) 
  The separations of two peaks relative to each other is described by the selectivity 
(or)  separation factor(α) which is determined by the ratio of the capacity factors of the two 
peaks. Separation factor represents the separation power o particular adsorbent to the 
particular Components. The ideal value of α is 2. It can be calculated by using the formula 
 
 
0t1tr
0t2tr
'1K
'2Kα


  
 K1’ = Capacity factor of first peak 
 K2’ = Capacity factor of second peak 
 tr1 = Retention time of first peak 
 tr2 = Retention time of second peak 
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 t0 = Initial time 
 
3. Resolution (Rs) 
  The degree of separation of one component from another is described by the 
resolution (RS) measured as the difference in retention time of the two solutes divided by 
their average peak width.  
 
 For base line separation the ideal value of RS is 1.5. It is calculated by using the formula. 
)2w1(w0.5
1tr2trRS


  
   
Rt1 and Rt2 are the retention times of components 1 and 2 
W1 and W2 are peak widths of components 1 and 2 
 
 These parameters may be within the ideal value means we can achieve better resolution. 
 
4. Selectivity (a) 
  The selectivity (or separation factor) a, is a measure of relative retention of two 
components in a mixture. The ideal value of selectivity is 2. It can be calculated by using 
the formula, 
1VV
1V2Vα


     
Where, 
V0 is the void volume of the column 
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V2 and V1 are the retention volumes of the second and the first peaks respectively. 
 
5. Theoretical factor or Column efficiency (N) 
  The efficiency of the chromatographic column is achieved by reducing the band 
spreading i.e., the more efficient the column, the smaller will be the width of the peak at a 
given retention time. It efficiency can be measured by the number of theoretical 
plates/meter (N) or plate height (H).Increase in the theoretical plates will show better 
column efficiency and system performance and it shows the less band spreading of a peak. 
2W
2Rt16N   
Where,  
Rt is the retention time and W is the peak width. 
 
6. Peak asymmetry factor (As) 
It can be used as a criterion of column performance. The peak half width ‘b’ of a 
peak at 10 % of the peak height divided by the corresponding front half width ‘a’ gives the 
asymmetry factor.  
 
a
bAs 
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2. DRUG PROFILE [www.Drugbank.com] 
 
Structure  
 
 
Cladribine 
Chemical name : 2-Chloro-2'-deoxyadenosine  
Chemical formula : C10H12ClN5O3 
Molecular weight : 285.687 g/mol 
Category  : hairy cell leukemia, B-cell chronic lymphocytic leukemia, 
B-cell chronic lymphocytic leukemia and relapsing remitting multiple sclerosis 
Description  : White to off-white powder. 
Solubility  : Freely soluble in water and in glacial acetic acid. 
Melting point             :     215 °C 
 
 
 
Chapter 2 Drug Profile 
Dept. of Pharmaceutical Analysis 37 JKKMMRF College of Pharmacy 
 
Indication 
    For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as 
defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related 
symptoms.  It’s also used as an alternative agent for the treatment of chronic lymphocytic 
leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma. 
Mechanism of action  
Cladribine is structurally related to fludarabine and pentostatin but has a different 
mechanism of action. Although the exact mechanism of action has not been fully 
determined, evidence shows that cladribine is phosphorylated by deoxycytidine kinase to 
the nucleotidecladribine triphosphate (CdATP; 2-chloro-2′-deoxyadenosine 5′-
triphosphate), which accumulates and is incorporated into DNA in cells such as 
lymphocytes that contain high levels of deoxycytidine kinase and low levels of 
deoxynucleotidase, resulting in DNA strand breakage and inhibition of DNA synthesis and 
repair. High levels of CdATP also appear to inhibit ribonucleotidereductase, which leads to 
an imbalance in tri-phosphorylateddeoxynucleotide (dNTP) pools and subsequent DNA 
strand breaks, inhibition of DNA synthesis and repair, nicotinamide adenine dinucleotide 
(NAD) and ATP depletion, and cell death. Unlike other antimetabolite drugs, cladribine 
has cytotoxic effects on resting as well as proliferating lymphocytes. However, it does 
cause cells to accumulate at the G1/S phase junction, suggesting that cytotoxicity is 
associated with events critical to cell entry into S phase. It also binds purine nucleoside 
phosphorylase (PNP), however no relationship between this binding and a mechanism of 
action has been established. 
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Pharmacokinetics 
      Cladribine is absorbed rapidly and oral bioavailability is 34 to 48%. 4.5 ±2.8 L/kg 
volumes should be distributed. Patients with hematologic malignancies 9L/kg volumes 
should be distributed. Cladribine is metabolized in all cells with deoxycytidine kinase 
activity to 2- chloro-2’deoxyadenosine- 5 –triphosphate. It is excreted by urine.   
 
Toxicity   
      Symptoms of overdose include irreversible neurologic toxicity (paraparesis/ 
Quadriparesis), acute nephrotoxicity and severe bone marrow suppression resulting in 
neutropenia, anemia and thrombocytopenia.  
 
Side effects:  
 constipation 
 diarrhea 
 dizziness 
 headache 
 joint pain 
 loss of appetite 
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 muscle pain 
 nausea 
 overall feeling of discomfort or illness 
 sleeping problems 
 unusual tiredness 
 vomiting 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 Drug Profile 
Dept. of Pharmaceutical Analysis 40 JKKMMRF College of Pharmacy 
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3. LITERATURE REVIEW 
  Literature review was carried out to enumerate the reported analytical methods for 
the selected drugs individually or in combination with other drugs. 
Panel James et al., 1994 High-performance liquid chromatography/mass 
spectrometer (HPLC/MS) was used to identify and structurally characterize the modified 
nucleoside cladribine (2-chloro-2′-deoxy-β-adenosine) and 13 synthesis-related byproducts 
in bulk drug. Confirmation of compound identity was accomplished by spectral analysis 
(1H and 13C NMR spectroscopy, mass spectrometry, and UV absorption spectroscopy) of 
the related compounds as isolated from crude mixtures of the drug substance and by 
spiking experiments with authentic standards. The use of on-line mass spectrometric 
analysis (i.e., LC/MS) to augment UV absorption spectra permitted rapid identification of 
many of the compounds of interest. 
Gajewska Met al., 1995A quantitative fluorescence assay for 2-chloro-2'-
deoxyadenosine (cladribine, leustatin, 2-CdA) in human plasma is described. The drug was 
isolated from plasma by ethyl acetate extraction and derivatized by a two-step procedure in 
which 2'-deoxyisoguanosine (2'-diG) was first prepared by UV irradiation of 2-CdA and 
was then treated with chloroacetaldehyde to form the fluorescent derivative, 1,N6-etheno-
2'-deoxyisoguanosine. Fluorescence intensity of the solutions was measured using an 
excitation wavelength of 275 nm and emission of 397 nm. The analytical measuring range 
of the method extends from about 1 microgram/l to at least 100 micrograms/l. 
Pollen KF et al.,2007To develop and validate a sensitive and specific HPLC 
assay for cladribine (CdA) in plasma for pharmacokinetic studies in rats. CdA and the 
internal standard AZT were purchased from Sigma-Aldrich Chem. The HPLC system 
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consisted of a Shimadzu LC-9A pump, a 3 μm, 250 x 2.0 mm I.D. high speed C18 column 
(Jupiter®), preceded by a 5 μm 4 x 4 mm I.D. C18 guard column (Licrocart), an Agilent 
Model 1050 UV-VIS detector and a 3395 Integrator. The mobile phase was made up of 
0.01M KH2PO4 (pH 5): methanol: acetonitrile (90:5:5). The system was operated at 
ambient temperature with a flow rate of 0.3 mL/min, and UV wavelength at 265 nm, and 
an operating pressure of 1.56 kpsi. Extraction of cladribine and AZT from plasma was 
achieved by solid phase extraction using 100 mg/mL C18 SPE columns (Extra-sep). The 
assay was validated for sensitivity, precision, specificity and application for 
pharmacokinetic study in rats.  Under these conditions, the average retention times of CdA 
and AZT were 13.5 and 21 min, respectively and recoveries were between 80 – 95%. 
Standard curve constructed from plasma standards was linear from 0.1 ug/mL to 1 ug/mL 
with regression coefficient (r2) 0.99 or greater. Sensitivity assessed by on column injection 
was < 1 ng. Using a 50-uL plasma sample size, the mean intra-assay variations at 
0.1ug/mL were 7%, and inter-assay variations over aperiod of 3 months for 5 separate 
batches were less than 20 %. The assay was used to study a singledose pharmacokinetic 
study of CdA in rats after a 2mg/kg subcutaneous injection. The described HPLC assay has 
adequate sensitivity and specificity to study pharmacokinetics of CdA in rats, and could be 
adapted also to clinical pharmacokinetic studies. 
BhairamBhoomaiahet al.,2012. A simple, precise and accurate RP-HPLC 
method was developed and validated for rapid assay of Cladribine in tablet dosage form. 
Isocratic elution at a flow rate of 1ml/min was employed on a symmetry Zodiac C18 
(250x4.6mm, 5μm in particle size) at ambient temperature. The mobile phase consisted of 
Methanol: Acetonitrile: Water in the ratio of 64:22:14%, v/v/v. The UV detection 
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wavelength was 231 nm and 20μl sample was injected. The retention time for Cladribine 
was 5.530 min. The percentage RSD for precision and accuracy of the method was found 
to be less than 2%. The method was validated as per the ICH guidelines. The method was 
successfully applied for routine analysis of Cladribine in tablet dosage form and bulk drug. 
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4. AIM AND PLAN OF WORK 
 
Cladribineis an anti-neoplastic agent used in the treatment of lympho proliferative 
diseases including hairy-cell leukemia. According to literature survey, very few analytical 
methods were reported especially in human plasma by spectrofluroimetry and 
Characterization of Cladribine and its related compounds was determined by HPLC/MS. 
Only one HPLC method was reported.  
The mobile phase consisted of methanol: acetonitrile: water in the ratio of 
64:22:14%v/v/v used for the existing method. Review of literature show that no HPLC 
methods have been reported for the drug with the selected mobile phase. Hence in this 
proposed project, an attempt shall be made to develop, optimize, reduce retention time and 
validate a HPLC method for the determination of cladribine bulk and in tablet dosage form 
as per ICH guidelines. 
 
PLAN OF WORK 
1. Identification, selection and collection of Cladribine for analysis. 
2. Development of simple and accurate RP-HPLC method using UV detection for the 
estimation of cladribinein bulk and in tablet dosage form. 
3. Statistical analysis of  the developed analytical method. 
4. The new method shall be validated for analytical parameters such as specificity, accuracy, 
precision, robustness, linearity and range as per the guidelines of ICH. 
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5. MATERIALS AND METHOD 
 
MATERIALS USED 
a. Drug samples and formulations 
  Cladribinepure samples and tablet formulation containing 10mg of were 
generously gifted by Apotex Research Private limited, Bangalore. 
 
b. Chemicals and Solvents used 
  
 
 
 
 
S.No Chemicals used GRADE MAKE 
1 Distilled  Water 
HPLC 
grade 
Millipore 
2 Acetonitrile 
HPLC 
grade 
Merck 
3 
Potassium di hydrogen 
phosphate 
AR grade Merck 
4 Ortho phosphoric acid AR grade Merck 
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c. Instruments  
Instruments employed for the study were 
1. Waters 2695 series HPLC with Empower 2 software with UV Detector 
2. Electronic balance (AFCOSET ER-200A) 
3. pH meter (ADWA  AD 1020) 
 
5.2 METHOD 
            The analysis of Cladribinewas done by the following method RP-HPLC 
 
RP-HPLC DEVELPOMENT AND OPTIMIZATION OF CHROMATOGRAPHIC 
PARAMETERS 
Method Development  
        In RP-HPLC, the retention of a compound is determined by its polarity, Pka, 
molecular weight, experimental conditions, mobile phase, column and temperature. The 
column (typically octyl (C8) and octadecyl (C18 ) bonded phase) is less polar than the water 
- organic phase, usually an almost or entirely mobile phase. Sample molecules partition 
between the polar mobile phase and non-polar C8 and C18 stationary phase and more 
hydrophobic (non-polar) compounds are retained more strongly. Polar compounds are less 
strongly held and elute from the column first and vice versa. Usually the lower polarity of 
the mobile phase having higher in its elution strength. RP-HPLC columns are efficient, 
stable and reproducible because of the solvents used. Generally gradient and isocratic 
elution techniques used for elution, isocratic elution technique empolyed for resolution of 
compounds in present study.   
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Selection of chromatographic method  
       Proper selection of the method depends upon the nature of sample,polarity, 
molecular weight, Pka value and solubility. The drug Cladribine for the present study 
waspolar. Hence Reverse phase chromatographic technique was selected by using C18 
column as a stationary phase and phosphate buffer (pH3.5): acetonitrile (70:30%v/v) as 
mobile phase. 
Detection of wavelength  
For many samples, good analytical results will be obtained only by careful selection 
of the wavelength used for detection. The sensitivity of HPLC depends upon proper 
selection of wavelength of detection. In order to determine the proper wavelength of the 
cladribinein mobile phase, spectra were scanned on UV-Visible spectrometer in the range 
of 200-400 and recorded the spectrum.It was found that cladribinehave marked absorbance 
at 235 nm and can be effectively used for the estimation of cladribine without interference. 
Therefore 235nm was selected as detection wavelength for the analysis of cladribine by 
RP-HPLC method with an isocratic elution technique. 
Preparation of Phosphate buffer  
      About7.0 grams of Potassium di hydrogen Phosphate was weighed and 
transferred into a 1000 ml standard flask, dissolve and diluted to 1000 ml with HPLC 
water. pH 3.5 wasadjusted with Ortho phosphoric acid. 
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Preparation of mobile phase 
      300 ml (30%) of phosphate buffer and 700 ml of Acetonitrile HPLC (70%) were 
mixed and degased in ultrasonic water bath for 5 minutes.  Then the solution was filtered 
through 0.45 µ filter under vacuum filtration. 
 
Initial Separation Condition 
 Mode of operation :           Isocratic 
  Instrument  : HPLC Waters 
Detector  : UV detector 
Column  : Symmetry C18 (4.6 x 150mm, 5 m, Make: XTerra) 
Temperature  : Ambient  
Flow rate  : 1.0 ml/min 
Wave length  : 235 nm 
Runtime  : 5 min 
Sample size  : 20 l 
Diluent  : Water: Methanol (50:50 % v/v) 
Quantification Method: External standard Calibration Method 
 
Effect of composition of mobile phase 
The different ratios of mobile phase weretried 50: 50, 40: 60 and 30: 70 % V/V. 
The chromatograms were recorded for all the above ratios. In the 30:70 %V/V with 
Phosphate buffer with pH 3.5 and Acetonitrile the retention time were less than the other 
used mobile ratios. Hence 30:70 %V/V mobile phase ratio was selected for further 
analysis. 
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Effect of pH of mobile phase 
The different pH solutions were tried i.e. 2.5, 3.0, 3.5 and the chromatograms were 
recorded. When comparing the chromatogram obtained for the different pH solutions, at 
pH 3.5, the peak was very sharp than the other pH solutions. So the pH 3.5 was selected. 
 
Optimized Chromatographic conditions 
The following parameters were used for RP-HPLC analysis of Cladribine 
 Mode of operation :           Isocratic 
 Instrument  : HPLC Waters 
 Detector  : UV detector 
 Column  : Symmetry C18 (4.6 x 150mm, 5 m, Make:  XTerra  
 Temperature  : Ambient  
Flow rate  : 1.0 ml/min 
Wave length  : 235 nm 
Runtime  : 5 min 
Sample size  : 20 l 
Mobile Phase  : Phosphate buffer: Acetonitrile (30:70 %v/v) 
 
Estimation of Cladribine in bulk and in tablet formulation 
         Estimation of Cladribine in bulk and in tablet forms by RP-HPLC was carried out by 
using optimized chromatographic conditions given above. 
  
Chapter 5 Materials and Method 
Dept. of Pharmaceutical Analysis 50 JKKMMRF College of Pharmacy 
Standard Solution Preparation 
10 mg of Cladribine working standard wasaccurately weighed and transferred into a 
10 ml volumetric flask. 7 ml of mobile phase was added and sonicate to dissolve it 
completely. Then made volume up to the mark with the same solvent (1000 μg/ml). 0.3 
ml(1 mg/ml) of the above stock solution was pipetted out and transferred into a 10 ml 
volumetric flask and dilute up to the mark with mobile phase (30μg/ml).  Then the solution 
was mixed well and filtered through 0.45 µm filter. 
Sample Solution Preparation 
       Ten tablets (Mavenclad 10mg) were weighed. The average weight was found and 
crushed to fine powder. The tablet powder equivalent to 10 mg was accurately weighed 
and transferred into a 10 ml volumetric flask.  About 7 ml of mobile phase was added and 
sonicate to dissolve it completely. Then the solution was made volume up to the volume 
with the mobile phase (1000 µg/ml). It was filtered through 0.45 µm filter. Further 0.3 ml 
of the above stock solution was pipetted out, transferred into a 10 ml volumetric flask and 
dilute up to the mark with mobile phase (30 µg/ml).  
Method Validation 
The RP-HPLC method was validated in terms of parameters like accuracy, linearity, 
precision, range, detection limit, quantification limit, ruggedness, robustness and system 
suitability etc. For all the parameters percentage relative standard deviation values were 
calculated. 
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System Suitability 
System suitability tests are an integral part of any chromatographic analysis method 
which is used to verify reproducibility of the chromatographic system. To ascertain its 
effectiveness, certain system suitability test parameters were checked by repetitively 
injecting the drug solution at the concentrations 30µg/ml to check the reproducibility of the 
system. 20 µL standard solutions were injected and chromatograms were recorded. 
 
Linearity (Calibration graph) 
From the stock standard (1000 µg/ml), the aliquots (0.1 to 0.5 ml of 1000 µg/ml) 
solution taken 0.1, 0.2, 0.3, 0.4, 0.5 ml were taken in a separate 10 ml volumetric flasks 
and made up to 10 ml with mobile phase. This solution can inject into the chromatographic 
system and record the Chromatogram. Cladribine showed linearity in the range of (10–50 
μg/ml). The calibration graph was plotted with peak area in the Y axis and concentration of 
standard solution in the X axis. The degree of linearity was estimated by calculating the 
correlation coefficient. 
 
Limit of Detection and Limit of Quantification: 
  LOD and LOQ values can be calculated with the help of linearity studies. The 
linearity study was performed three times and calibration graph was plotted. Calculate the 
value of slope, intercept from the calibration graph. LOD and LOQ can be calculated by 
using the following formula. 
  LOD = 3.3(SD/S) 
  LOQ = 10(SD/S) 
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Content estimation (Assay): 
Ten tablets (Mavenclad 10mg) were weighed. The average weight was found and 
crushed to fine powder. The tablet powder equivalent to 10 mg was accurately weighed 
and transferred into a 10 ml volumetric flask.  About 7 ml of mobile phase was added and 
sonicate to dissolve it completely. Then the solution was made volume up to the volume 
with the mobile phase (1000 µg/ml). It was filtered through 0.45 µm filter. Further 0.3 ml 
of the above stock solution was pipetted out, transferred into a 10 ml volumetric flask and 
dilute up to the mark with mobile phase (30µg/ml). 20 µl of blank, standard and sample 
solution were injected and the chromatograms were recorded. The % purity of the sample 
(tablet)was calculated by the following formula 
100X
ClaimLabel
Avg.Wtx
100
Px
WT
DTx
DS
WSx
AS
AT%Assay 
 
AT = Peak Area of cladribineobtained with test preparation 
 AS = Peak Area of cladribineobtained with standard preparation                                                                                                    
WS = Weight of working standard taken in mg 
 WT = Weight of sample taken in mg  
 DS = Dilution of Standard solution 
 DT = Dilution of sample solution 
 P  = Percentage purity of working standard  
 
 
 
 
Chapter 5 Materials and Method 
Dept. of Pharmaceutical Analysis 53 JKKMMRF College of Pharmacy 
Precision 
The precision of an analytical procedure expresses the closeness of 
agreement(degree of scatter) between a series of measurements obtained from 
multiplesamples of the same homogeneous sample under prescribed conditions. Precision 
is usually investigated at three levels: repeatability, intermediate precision,and 
reproducibility. 
 
Accuracy 
A study of accuracy was conducted. Drug assay was performed in triplicate by 
spiking with equivalent amount of cladribine raw material into each volumetric flask for 
each spike level to get the concentration of cladribine equivalent to 50%, 100%, and 150% 
of the labelled amount ofcladribine as per the test method. The average percentage 
recovery of cladribine was calculated. 
 
Robustness 
The  robustness of the analytical method is a measure of its capacity to remain 
uneffectedby small but deliberate variation in method parameters and provides an 
indication of its reliability during normal usage. 
For demonstarting the robustness of the method,the optimized flow rate and 
composition of mobile phase condition was slightly changed these were 0.8  mLmin-1 and 
1.2mLmin-1 , organic composition of mobile phase were (40:60 %v/v) and (20:80%v/v).20 
µL standard solutions were injected and chromatograms were recorded. 
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6. RESULTS AND DISCUSSION 
 
RP-HPLC method was developed for the determination Cladribine bulk and in 
tablet dosage form. To optimize the proposed HPLC  method, all of the experimental 
conditions were investigated. For the choice of the stationary phase, reverse phase 
seperation was preferred due to the drawbacks of the normal phase, for the seperation of 
mobile phase different systems were tried for effective chromatographic seperation. 
10 μg/ml of cladribine in mobile phase (Phosphate buffer pH 3.5: Acetonitrile 
30:70%v/v) solution was prepared and it was scanned in the UV region. At 235 nm the 
drug showed maximum absorbance. Hence this was selected as a detection wavelength. 
The UV spectrum was shown in figure 2a. Quantification was done by Standard addition 
method. 
 
FIGURE – 2a 
UV SPECTRUM OF CLADRIBINE  IN PHOSPHATE BUFFER pH 3.5: 
ACETONITRILE (30:70 %v/v) 
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  The optimization was done by the confirmation of mobile phase, changing pH 
value of phosphate buffer and flow rate. Methanol, acetonitrile, Phosphate buffer were 
tried in the method. Blank was run with the help of Acetonitrile and Phosphate buffer in 
the ratio of 70:30% v/v. This was shown in the figure 3. Water and Methanol was used as 
mobile phase in the ratio of 50:50 % v/v and the flow rate was 1.0 ml/min. Water and 
Acetonitrile was used as mobile phase in the ratio of  40:60% v/v and the flow rate was 1.0 
ml/min. Phosphate buffer (pH 3.0) and Methanol was used as mobile phase in the ratio of 
50:50% v/v and the flow rate was 1.0 ml/min. Phosphate buffer (pH 3.5) and Methanol was 
used as mobile phase in the ratio of 40:60% v/v and the flow rate was 1.0 ml/min. 
Phosphate buffer (pH 3.5) and Acetonitrile  was used as mobile phase in the ratio of 
40:60% v/v and the flow rate was 1.0 ml/min. Phosphate buffer (pH 3.5) and Acetonitrile 
was used as mobile phase in the ratio of 30:70% v/v and the flow rate was 1.0 ml/min. The 
chromatograms were shown in figures 4-9. After considering all system suitability 
parameters in different ratios, different pH, Phosphate buffer pH 3.5 and Acetonitrile in the 
ratio of 30:70% v/v with 1.0 ml/min flow rate was selected for the further studies. 
Optimized chromatogram was shown in figure 10. The retention time for cladribine was 
found to be 3.195 minutes. 
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FIGURE -3 CHROMATOGRAM OF BLANK BY HPLC METHOD (PHOSPHATE 
BUFFER pH 3.5: ACETONITRILE (30:70 %v/v) 
 
FIGURE 4 CHROMATOGRAM OF CLADRIBINE IN WATER: METHANOL (50: 50 
%V/V) BY HPLC METHOD 
 Peak name  RT Area Height USP plate count USP Tailing 
1 Cladribine 3.916 1760477 63310 480.7 1.3 
 Baseline Noise (mV) 
1             0.048 
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FIGURE 5 
CHROMATOGRAM OF CLADRIBINEIN WATER: ACETONITRILE (40: 60 %V/V) 
BY HPLC METHOD 
 Peak name  RT Area Height USP plate count USP Tailing 
1 Cladribine 3.919 1650713 59758 509.6 1.2 
 
 
 FIGURE – 6  
CHROMATOGRAM OF CLADRIBINE IN PHOSPHATE BUFFER pH3: METHANOL 
(50: 50%V/V) BY HPLC METHOD 
 Peak name  RT Area Height USP plate count USP Tailing 
1 Cladribine 3.894 691820 49018 1780.6 1.6 
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FIGURE – 7 
 
CHROMATOGRAM OF CLADRIBINE IN PHOSPHATE BUFFER pH3.5: METHANOL 
(40: 60%V/V) BY HPLC METHOD 
 
 Peak name  RT Area Height USP plate count USP Tailing 
1 Cladribine 3.211 956842 86400 1883.7 1.3 
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FIGURE – 8 
CHROMATOGRAM OF CLADRIBINE IN PHOSPHATE BUFFER pH3.5: 
ACETONITRILE (40: 60%V/V) BY HPLC METHOD 
 
 Peak name  RT Area Height USP plate count USP Tailing 
1 Cladribine 3.849 1075343 82659 2050.8 1.4 
 
 
FIGURE – 9 
CHROMATOGRAM OF CLADRIBINE IN PHOSPHATE BUFFER pH3.5: 
ACETONITRILE (30: 70%V/V) BY HPLC METHOD 
 Peak name  RT Area Height USP plate count USP Tailing 
1 Cladribine 3.195 1058299 102124 2178.3 1.4 
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FIGURE – 10 
OPTIMIZED CHROMATOGRAM OF CLADRIBINE BY HPLC METHOD 
 
 Peak name  RT Area Height USP plate count USP Tailing 
1 Cladribine 3.195 1058299 102124 2178.3 1.4 
 
  The system suitability tests ensured the validity of the analytical procedure as well 
as confirmed the resolution between different peaks of interest. Acceptance criteria for 
system suitability were asymmetry factor should not be more than 2.0, theoretical plates 
should not be less than 2000 and %RSD of peak area should not be more than 2.0. All 
variation parameters results were within the acceptance criteria mentioned above. The 
result of system suitability study of the developed assay method was shown in table 3. 
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TABLE -3 
SYSTEM SUITABILITY OF CLADRIBINE BY HPLC METHOD 
 
Parameter Cladribine 
Tailing factor 1.6 
No of Theoretical plate 2951 
Retention time 3.2 
 
 
  With the optimized chromatographic conditions, stock solutions of cladribine was 
prepared by using mobile phase ( phosphate buffer pH 3.5 and Acetonitrile in the ratio 
(30:70 %v/v) and various concentrations were prepared in the range of 10-50 µg/ml and 
injected individually. The chromatograms were recorded at 235 nm. The chromatograms 
were shown in the figures 11 - 15. The report of linearity studies were shown in table 4. 
The calibration curve was plotted by using concentration against peak area. The correlation 
coefficient was found to be 0.999. This indicated that the concentration of cladribinehad 
good linearity. The calibration curve was shown in figure 16. 
TABLE -4 
LINEARITY OF CLADRIBINE BY HPLC METHOD 
S.No 
Concentration of  
Cladribine 
Peak Area LOD LOQ 
1 10 1323634 
0.014 0.0465 
2 20 2712792 
3 30 3998490 
4 40 5328851 
5 50 6652686 
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FIGURE –11 
LINEARITY CHROMATOGRAM OF CLADRIBINE 10µG/ML BY HPLC METHOD 
 
 
 
 
 
FIGURE – 12 
LINEARITY CHROMATOGRAM OF CLADRIBINE 20µG/MLBY HPLC METHOD 
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FIGURE – 13 
LINEARITY CHROMATOGRAM OF CLADRIBINE 30µG/ML BY HPLC METHOD 
 
 
 
 
FIGURE – 14 
LINEARITY CHROMATOGRAM OF CLADRIBINE 40µG/ML BY HPLC METHOD 
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FIGURE – 15 
LINEARITY CHROMATOGRAM OF CLADRIBINE 50µG/ML BY HPLC 
METHOD 
 Sample name Peak name RT Area Height 
1 Linearity 10ppm Cladribine 3.189 1113634 102352 
2 Linearity 20ppm Cladribine 3.175 2712792 244484 
3 Linearity 30ppm Cladribine 3.187 3908404 342239 
4 Linearity 40ppm Cladribine 3.180 5328851 484112 
5 Linearity 50ppm Cladribine 3.187 6652686 555333 
 
 
 
FIGURE – 16 
CALIBRATION CURVE OF CLADRIBINE BY HPLC METHOD 
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The limit of detection and the limit of quantification were determined based on the 
signal to noise ratio. The limit of detection was found to be 0.014 µg/ml and the limit of 
quantification was found to be 0.0465 µg/ml. The chromatogram for LOD and LOQ were 
shown in the figure 17 and 18 respectively. The value obtained in the LOD and LOQ was 
shown in the table 4. 
 
 
 
FIGURE – 17 
LOD CHROMATOGRAM OF CLADRIBINE BY HPLC METHOD 
 
 
 
 
 Name Retention Time Area (µV*sec) Height (µV) 
1 Cladribine 3.189 1545 142 
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FIGURE – 18 
LOQ CHROMATOGRAM OF CLADRIBINE BY HPLC METHOD 
 
 
 
 
 
Assay was performed to determine the purity of the drug. 30 µg/ml solutions were 
prepared by using pure drug and sample. 20 μl of each solution were injected individually. 
The chromatogram was recorded at 235 nm. The percentage purity of the cladribine was 
found to be 100.7%. The chromatograms were shown in figures 19-22. 
 
 
FIGURE – 19 
ASSAY CHROMATOGRAM OF CLADRIBINE SAMPLE ( I )      
 BY HPLC METHOD 
 Name Retention Time Area (µV*sec) Height (µV) 
1 Cladribine 3.188 5277 485 
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FIGURE – 20 
ASSAY CHROMATOGRAM OF CLADRIBINE SAMPLE ( II ) 
 BY HPLC METHOD 
 
 
 
 
 
 
FIGURE – 21 
ASSAY CHROMATOGRAM OF CLADRIBINE STANDARD ( I ) 
 BY HPLC METHOD 
 Peak Name  RT Injection  Area 
1 Cladribine 3.181 1 3912105 
2 Cladribine 3.181 2 3907203 
Mean    3909654 
SD    3466.4 
%RSD    0.09 
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FIGURE – 22 
ASSAY CHROMATOGRAM OF CLADRIBINE STANDARD ( II ) 
BY HPLC METHOD 
 
 
 
Accuracy was confirmed by recovery studies by adding known amount of pure drug 
to the previously analysed formulation and the mixture was analysed by proposed method 
and chromatograms were shown in the figures 23-31. The percentage recovery of 
cladribine present in formulation was found to be 101.28%. The proposed method was 
validated and the results were shown in the table 5. The result shows that the excipients 
and additives did not interfering the developed method. Hence the accuracy of the method 
was confirmed. 
 
 
 
 
 
 
 
 
 Name Retention Time Area USP Plate Count USP Tailing 
1 Cladribine 3.209 3775367 2860.4 1.6 
2 Cladribine 3.178 3774231 2896.4 1.2 
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TABLE -5 
RECOVERY STUDY CLADRIBINEOF BY HPLC METHOD 
 
%Concentration 
(at specification 
Level) 
Area 
Amount 
Added 
(mg) 
Amount 
Found 
(mg) 
% Recovery Mean Recovery 
50% 2110613 5.5 5.57 101.3% 
101.3% 100% 3885698 10.1 10.2 101.5% 
150% 5778169 15.1 15.2 101.0% 
 
 
 
 
 
 
 
FIGURE –23 
RECOVERY CHROMATOGRAM OF CLADRIBINE 50% BY HPLC METHOD 
(1) 
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FIGURE –24 
RECOVERY CHROMATOGRAM OF CLADRIBINE 50% BY HPLC METHOD 
(II) 
 
 
 
FIGURE –25 
RECOVERY CHROMATOGRAM OF CLADRIBINE 50% BY HPLC METHOD 
(III) 
 Peak 
name 
RT Injection Area 
1 Cladribine 3.184 1 2108215 
2 Cladribine 3.235 2 2109521 
3 Cladribine 3.184 3 2114103 
Mean    2110613 
SD    3092.0 
%RSD    0.15 
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FIGURE – 26 
RECOVERY CHROMATOGRAM OF CLADRIBINE 100%BY HPLC METHOD 
(I) 
 
 
FIGURE – 27 
RECOVERY CHROMATOGRAM OF CLADRIBINE 100%BY HPLC METHOD 
(II) 
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FIGURE – 28 
RECOVERY CHROMATOGRAM OF CLADRIBINE 100%BY HPLC METHOD 
(III) 
 
 
FIGURE – 29 
RECOVERY CHROMATOGRAM OF CLADRIBINE 150%BY HPLC METHOD 
(I) 
 
 Peak 
name 
RT Injection Area 
1 Cladribine 3.191 1 3875174 
2 Cladribine 3.217 2 3888449 
3 Cladribine 3.191 3 3893469 
Mean    3885698 
SD    9452.9 
%RSD    0.24 
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FIGURE – 30 
RECOVERY CHROMATOGRAM OF CLADRIBINE 150%BY HPLC METHOD 
(II) 
 
 
FIGURE – 31 
RECOVERY CHROMATOGRAM OF CLADRIBINE 150%BY HPLC METHOD 
(III) 
 Peak 
name 
RT Injection Area 
1 Cladribine 3.189 1 5781825 
2 Cladribine 3.238 2 5779001 
3 Cladribine 3.189 3 5773680 
Mean    5778169 
SD    4135.7 
%RSD    0.07 
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  Precision study was done with 30 µg/ml solution of cladribinestandard was 
prepared from the stock solution. 20 μl of each standard was injected and the 
chromatograms were recorded. This procedure was repeated for five times. The % RSD 
was found to be 1.44. The % RSD for the area of five replicate injections was found to be 
within the specified limit. This indicated that the developed method had good precision 
with repeatability.The results were shown in table 6 and the chromatograms were shown in 
figure 32-36. 
TABLE -6 
PRECISION OFCLADRIBINE BY HPLC METHOD 
S.No Concentration of Cladribine 
Peak 
Absorbance Average SD %RSD 
1 10 3855508 
3870622 10815.8 0.28 
2 20 3865126 
3 30 3871273 
4 40 3878408 
5 50 3882797 
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FIGURE – 32 
PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml) 
BY HPLC   METHOD (1) 
 
 
 
 
FIGURE – 33 
PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml) 
BY HPLC   METHOD (2) 
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FIGURE – 34 
PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml) 
BY HPLC   METHOD (3) 
 
 
 
 
 
FIGURE – 35 
PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml) 
BY HPLC   METHOD (4) 
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FIGURE – 36 
PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml) 
BY HPLC   METHOD (5) 
 
 
 
 Intermediate precision study was done with 30 µg/ml solution of cladribine standard was 
prepared from the stock solution. The % RSD was found to be 0.28. The % RSD for the 
area of five replicate injections was found to be within the specified limit. It showed the 
intermediate precision was within the specified limit. The report of analysis was shown in 
table 7 and the chromatograms were shown in the figure37-41. 
 
 Peak 
name 
RT Injection Area 
1 Cladribine 3.189 1 3855508 
2 Cladribine 3.198 2 3865126 
3 Cladribine 3.178 3 3871273 
4 Cladribine 3.212 4 3878407 
5 Cladribine 3.189 5 3882797 
Mean    3870622 
SD    10815.8 
%RSD    0.28 
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TABLE -7 
INTERMEDIATE PRECISION OFCLADRIBINE BY HPLC METHOD 
S.No Concentration of Cladribine 
Peak 
Absorbance Average SD %RSD 
1 10 4095410 
3992318 61140.1 1.53 
2 20 3935121 
3 30 3963812 
4 40 3990300 
5 50 3976949 
 
 
FIGURE – 37 
 INTERMEDIATE PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml)  
BY HPLC   METHOD (1) 
 
 
FIGURE – 38 
INTERMEDIATE PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml) 
BY HPLC   METHOD (2) 
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FIGURE – 39 
INTERMEDIATE PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml)  
BY HPLC   METHOD (3) 
 
 
 
 
FIGURE – 40 
INTERMEDIATE PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml)  
BY HPLC   METHOD (4) 
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FIGURE – 41 
INTERMEDIATE PRECISION CHROMATOGRAM OF CLADRIBINE (30 μg/ml)  
BY HPLC   METHOD (5) 
 
 
 
 
 
 
 
  Robustness was performed by changing the flow rate and by changing the organic 
composition of the mobile phase. The chromatograms for robustness were shown in the 
figure 42- 45. The results were shown in the table 8. It showed that there was no change in 
the values even after making deliberate change in the analytical procedure.  
All the above parameters combined with the simplicity and ease of operation ensures that 
the application of proposed method in the assay of drug in pharmaceutical dosage form. 
Hence the RP-HPLC method may be applied for the estimation of cladribinein bulk and in 
tablet dosage form. 
 Peak name RT Injection Area 
1 Cladribine 3.213 1        4095410 
2 Cladribine 3.217 2        3935121  
3 Cladribine 3.183 3   3963812 
4 Cladribine 3.261 4        3990300 
      5 Cladribine 3.261 5 3976949 
  Mean    3992318 
   SD            61140.1 
%RSD    1.53 
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TABLE -8 
ROBUSTNESS OF CLADRIBINE BY HPLC METHOD 
Parameters Theoretical Plate Tailing Factor 
Less flow (0.5 ml/min) 2889 1.6 
More flow (0.7 ml/min) 2961 1.5 
Less organic phase (60 %) 2874 1.6 
More organic phase (80%) 2856 1.5 
 
 
 
 
FIGURE – 42 
ROBUSTNESS CHROMATOGRAM OF CLADRIBINE (LESS FLOW) 
BY HPLC METHOD 
 
 
 Name Retention Time Area (µV*sec) USP plate count USP 
Tailing 
1 Cladribine 3.834       4694313 2889.4    1.6 
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FIGURE – 43 
ROBUSTNESS CHROMATOGRAM OF CLADRIBINE (MORE FLOW) 
BY HPLC METHOD 
 
 
FIGURE – 44 
ROBUSTNESS CHROMATOGRAM OFCLADRIBINE (LESS ORGANIC) 
BY HPLC METHOD 
 Name Retention Time Area (µV*sec) USP plate 
count 
USP Tailing 
1 Cladribine 2.728 32316666 2961.0 1.5 
 Name Retention Time Area (µV*sec) USP plate count USP 
Tailing 
1 Cladribine 3.221 3860449 2874.9 1.6 
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FIGURE –45 
 
ROBUSTNESS CHROMATOGRAM OF CLADRIBINE (MORE ORGANIC) 
BY HPLC METHOD 
 
 
 
 
 
 
 
 
 
 
 
 Name Retention Time Area (µV*sec) USP Plate count USP 
Tailing 
1 Cladribine 3.225 3828751 2856.9 1.5 
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7. SUMMARY AND CONCLUSION 
 
Based on the validation results the proposed HPLC method is proven to be suitable 
as well as found to be simple, specific, precise and accurate for the determination of 
cladribine in bulk and tablet dosage form. 
RP-HPLC Method 
  Cladribine was determined by RP-HPLC method with external standard 
calibration method. A wavelength of 235 nm was selected as a detection wavelength for 
the estimation cladribine. Different pH like 2.5, 3.0, and 3.5 were tried and finally pH 3.5 
was selected. Optimization of chromatographic parameters was done. Parameters 
optimized were effect of mobile phase and effect of pH. Phosphate buffer pH 3.5 and 
Acetonitrile in the ratio of 30:70 %v/v was selected as mobile phase for the present study. 
 
  With the optimized chromatographic conditions, a stock solution of cladribine 
was prepared and dilution was done using mobile phase from the stock solution. Serial 
dilutions of 10-50 µg/ml of cladribine were prepared. The solutions were injected and the 
chromatograms were recorded. From the calibration curve it was found that the drug 
cladribine linear in the srange of 10-50 µg/ml. The correlation coefficient was found to be 
0.999. Slope 13304 and intercept 10020. The percentage purity of the cladribine was found 
to be 100.7%.  
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  The recovery studies were also carried out to ensure the accuracy of the method 
by adding known concentration of drug to a pre-analysed formulation. The average 
percentage recovery was found to be 101.28%. The % RSD for the precision was 0.28 and 
The Intermediate precision % RSD was found to be 1.53.Thus these two methods can be 
effectively used for the routine analysis of cladribine. 
 
Robustness shows that there is no change in the values even after making deliberate 
change in the analytical procedure. 
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